Summary

US Angioplasty Balloons Market is valued approximately at USD 619.28 million in 2023 and is anticipated to grow with a healthy growth rate of more than 2.60% over the forecast period 2024-2032. Angioplasty balloons are medical devices in order to treat blocked or constricted blood arteries, especially in the heart and other parts of the body. The damaged artery is opened by inserting a catheter with a connected balloon, which is then inflated at the blockage location to compress the plaque or fatty deposits and enlarge the conduit and restore blood flow. This procedure enhances cardiovascular health in general by reducing symptoms of diseases including peripheral arterial disease and coronary artery disease. Drug-coated angioplasty balloons and bioresorbable stents are becoming increasingly popular because they provide better long-term results and increased effectiveness over conventional devices. Furthermore, a growing number of angioplasty techniques are using artificial intelligence (AI) and machine learning, which allows for more accurate treatment planning and improved patient results. These trends highlight the US angioplasty balloons market's ongoing need for improved treatment alternatives and patient care. Accordingly, the increasing demand for innovative technologies and techniques to address complex cardiovascular conditions is a key trend for the US Angioplasty Balloons Market.

The rising prevalence of various cardiovascular conditions such as atherosclerosis and peripheral arterial disease and region's strong healthcare infrastructure are the key factors that are bolstering the demand of the US Angioplasty Balloons Market at a substantial rate. According to the Journal of the American College of Cardiology published in February 2023, the incidence rate of atherosclerotic cardiovascular disease per 1,000 person-years was 2.60 among those with raised 10-year predicted risk, 1.87 among those with low 10-year however increased 30-year predicted risk, and 0.32 among those with low 10-year and 30-year predicted risk. Furthermore, favorable regulatory policies and approvals for innovative angioplasty devices have encouraged market players to invest in research and development, leading to new product launches and market expansion, which are further presenting various growth prospects to the US Angioplasty Balloons Market during the forecast period. However, high costs associated with the procedure, coupled with the complications associated with angioplasty procedures is expected to stifle US Angioplasty Balloons Market growth between 2022 and 2032.


Major market player included in this report are:
Abbott Laboratories
Becton, Dickinson and Company
Boston Scientific Corporation
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10



The detailed segments and sub-segment of the market are explained below:

By Product Type
Normal Balloons
Cutting/Scoring Balloons
Drug Eluting Balloons

By Application
Coronary Angioplasty
Peripheral Angioplasty

By End User
Hospitals
Ambulatory Surgical Centers
Other End Users


Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. US Angioplasty Balloons Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. US Angioplasty Balloons Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Product Type
2.2.2. By Application
2.2.3. By End User
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
Chapter 3. US Angioplasty Balloons Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. US Angioplasty Balloons Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. US Angioplasty Balloons Market Size & Forecasts by Product Type 2022-2032
5.1. Normal Balloons
5.2. Cutting/Scoring Balloons
5.3. Drug Eluting Balloons
Chapter 6. US Angioplasty Balloons Market Size & Forecasts by Application 2022-2032
6.1. Coronary Angioplasty
6.2. Peripheral Angioplasty
Chapter 7. US Angioplasty Balloons Market Size & Forecasts by End User 2022-2032
7.1. Hospitals
7.2. Ambulatory Surgical Centers
7.3. Other End Users
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Becton, Dickinson and Company
8.3.3. Boston Scientific Corporation
8.3.4. Company 4
8.3.5. Company 5
8.3.6. Company 6
8.3.7. Company 7
8.3.8. Company 8
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes